{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T19:30:55Z","timestamp":1767987055106,"version":"3.49.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T00:00:00Z","timestamp":1534204800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00345-018-2438-9","type":"journal-article","created":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T10:29:10Z","timestamp":1534242550000},"page":"51-60","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["ICUD-SIU International Consultation on Bladder Cancer 2017: management of non-muscle invasive bladder cancer"],"prefix":"10.1007","volume":"37","author":[{"given":"Leonardo L.","family":"Monteiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Alfred","family":"Witjes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piyush K.","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher B.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trinity J.","family":"Bivalacqua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard H.","family":"Bochner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joost L.","family":"Boormans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam S.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose L.","family":"Dom\u00ednguez-Escrig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"McKiernan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Dinney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilherme","family":"Godoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Girish S.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paramananthan","family":"Mariappan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrill A.","family":"Rentsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay B.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Solsona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Svatek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine G.","family":"van der Heijden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. Johannes P.","family":"van Valenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wassim","family":"Kassouf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,14]]},"reference":[{"issue":"5","key":"2438_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359\u2013E386. https:\/\/doi.org\/10.1002\/ijc.29210","journal-title":"Int J Cancer"},{"issue":"3","key":"2438_CR2","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00345-009-0383-3","volume":"27","author":"M Ploeg","year":"2009","unstructured":"Ploeg M, Aben KK, Kiemeney LA (2009) The present and future burden of urinary bladder cancer in the world. World J Urol 27(3):289\u2013293. https:\/\/doi.org\/10.1007\/s00345-009-0383-3","journal-title":"World J Urol"},{"issue":"1","key":"2438_CR3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","volume":"71","author":"S Antoni","year":"2017","unstructured":"Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F (2017) Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol 71(1):96\u2013108. https:\/\/doi.org\/10.1016\/j.eururo.2016.06.010","journal-title":"Eur Urol"},{"issue":"2","key":"2438_CR4","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","volume":"63","author":"M Burger","year":"2013","unstructured":"Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, Kassouf W, Kiemeney LA, La Vecchia C, Shariat S, Lotan Y (2013) Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63(2):234\u2013241. https:\/\/doi.org\/10.1016\/j.eururo.2012.07.033","journal-title":"Eur Urol"},{"key":"2438_CR5","unstructured":"Philips B, Ball C, Sackett D, et al (2009) Oxford Centre for Evidence-based medicine\u2014levels of evidence (March 2009). http:\/\/www.cebm.net\/oxford-centre-evidence-based-medicine-levels-evidence-march-2009\/ . Accessed 15 June, 2017"},{"key":"2438_CR6","volume-title":"TNM classification of malignant tumours","author":"LH Sobin","year":"2010","unstructured":"Sobin LH, Gospodarowicz MK, Wittekind C (2010) TNM classification of malignant tumours, 7th edn. Wiley-Blackwell, Chichester","edition":"7"},{"key":"2438_CR7","volume-title":"TNM classification of malignant tumours","author":"JD Brierley","year":"2017","unstructured":"Brierley JD, Gospodarowicz MK, Wittekind C (2017) TNM classification of malignant tumours, 8th edn. Wiley-Blackwell, Chichester","edition":"8"},{"issue":"3","key":"2438_CR8","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","volume":"49","author":"RJ Sylvester","year":"2006","unstructured":"Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, Newling DW, Kurth K (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49(3):466\u2013477. https:\/\/doi.org\/10.1016\/j.eururo.2005.12.031","journal-title":"Eur Urol"},{"issue":"5","key":"2438_CR9","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/j.juro.2009.07.016","volume":"182","author":"J Fernandez-Gomez","year":"2009","unstructured":"Fernandez-Gomez J, Madero R, Solsona E, Unda M, Martinez-Pineiro L et al (2009) Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model. J Urol 182(5):2195\u20132203. https:\/\/doi.org\/10.1016\/j.juro.2009.07.016","journal-title":"J Urol"},{"issue":"3","key":"2438_CR10","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0094-0143(21)00414-6","volume":"19","author":"MS Soloway","year":"1992","unstructured":"Soloway MS, Patel J (1992) Surgical techniques for endoscopic resection of bladder cancer. Urol Clin North Am 19(3):467\u2013471","journal-title":"Urol Clin North Am"},{"issue":"3","key":"2438_CR11","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/S0022-5347(05)67824-X","volume":"163","author":"R Ukai","year":"2000","unstructured":"Ukai R, Kawashita E, Ikeda H (2000) A new technique for transurethral resection of superficial bladder tumor in 1 piece. J Urol 163(3):878\u2013879. https:\/\/doi.org\/10.1016\/S0022-5347(05)67824-X","journal-title":"J Urol"},{"key":"2438_CR12","unstructured":"Bladder cancer. A Joint SIU-ICUD International Consultation. Lisbon, Portugal. Available at: http:\/\/www.siu-urology.org\/society\/siu-icud . Accessed 19 Oct, 2017 In press"},{"issue":"1","key":"2438_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/RCT.0b013e3181b728ae","volume":"34","author":"M Koplay","year":"2010","unstructured":"Koplay M, Kantarci M, Guven F, Aksoy Y, Taser F, Ziypak T, Eren S, Levent A, Atamanalp SS (2010) Diagnostic efficiency of multidetector computed tomography with multiplanar reformatted imaging and virtual cystoscopy in the assessment of bladder tumors after transurethral resection. J Comput Assist Tomogr 34(1):121\u2013126. https:\/\/doi.org\/10.1097\/RCT.0b013e3181b728ae","journal-title":"J Comput Assist Tomogr"},{"issue":"7","key":"2438_CR14","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1007\/s00330-009-1340-7","volume":"19","author":"A El-Assmy","year":"2009","unstructured":"El-Assmy A, Abou-El-Ghar ME, Mosbah A, El-Nahas AR, Refaie HF, Hekal IA, El-Diasty T, el Ibrahiem H (2009) Bladder tumour staging: comparison of diffusion- and T2-weighted MR imaging. Eur Radiol 19(7):1575\u20131581. https:\/\/doi.org\/10.1007\/s00330-009-1340-7","journal-title":"Eur Radiol"},{"issue":"5","key":"2438_CR15","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.2214\/AJR.08.1430","volume":"192","author":"H Watanabe","year":"2009","unstructured":"Watanabe H, Kanematsu M, Kondo H, Goshima S, Tsuge Y, Onozuka M, Moriyama N (2009) Preoperative T staging of urinary bladder cancer: does diffusion-weighted MRI have supplementary value? AJR Am J Roentgenol 192(5):1361\u20131366. https:\/\/doi.org\/10.2214\/AJR.08.1430","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"2438_CR16","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/j.1464-410X.2010.09212.x","volume":"106","author":"M Lodde","year":"2010","unstructured":"Lodde M, Lacombe L, Friede J, Morin F, Saourine A, Fradet Y (2010) Evaluation of fluorodeoxyglucose positron-emission tomography with computed tomography for staging of urothelial carcinoma. BJU Int 106(5):658\u2013663. https:\/\/doi.org\/10.1111\/j.1464-410X.2010.09212.x","journal-title":"BJU Int"},{"issue":"5","key":"2438_CR17","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.clinimag.2009.07.004","volume":"34","author":"A Saokar","year":"2010","unstructured":"Saokar A, Islam T, Jantsch M, Saksena MA, Hahn PF, Harisinghani MG (2010) Detection of lymph nodes in pelvic malignancies with computed tomography and magnetic resonance imaging. Clin Imaging 34(5):361\u2013366. https:\/\/doi.org\/10.1016\/j.clinimag.2009.07.004","journal-title":"Clin Imaging"},{"issue":"3","key":"2438_CR18","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","volume":"71","author":"M Babjuk","year":"2017","unstructured":"Babjuk M, Bohle A, Burger M, Capoun O, Cohen D, Comperat EM, Hernandez V, Kaasinen E, Palou J, Roupret M, van Rhijn BW, Shariat SF, Soukup V, Sylvester RJ, Zigeuner R (2017) EAU guidelines on non-muscle invasive bladder cancer: update 2016. Eur Urol 71(3):447\u2013461. https:\/\/doi.org\/10.1016\/j.eururo.2016.05.041","journal-title":"Eur Urol"},{"issue":"4","key":"2438_CR19","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","volume":"196","author":"S Chang","year":"2016","unstructured":"Chang S, Boorjian S, Chou R, Clark PE, Daneshmand S, Konety BR, Pruthi R, Quale DZ, Ritch CR, Seigne JD, Skinner EC, Smith ND, McKiernan JM (2016) Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SOU guidelines. J Urol 196(4):1021\u20131029. https:\/\/doi.org\/10.1016\/j.juro.2016.06.049","journal-title":"J Urol"},{"issue":"2","key":"2438_CR20","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/S0022-5347(01)65180-2","volume":"157","author":"C Goessl","year":"1997","unstructured":"Goessl C, Knispel HH, Miller K, Klan R (1997) Is routine excretory urography necessary at first diagnosis of bladder cancer? J Urol 157(2):480\u2013481. https:\/\/doi.org\/10.1016\/S0022-5347(01)65180-2","journal-title":"J Urol"},{"issue":"3","key":"2438_CR21","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1097\/01.ju.0000169424.79702.6d","volume":"174","author":"J Palou","year":"2005","unstructured":"Palou J, Rodriguez-Rubio F, Huguet J, Segarra J, Ribal MJ, Alcaraz A, Villavicencio H (2005) Multivariate analysis of clinical parameters of synchronous primary superficial bladder cancer and upper urinary tract tumor. J Urol 174(3):859\u2013861. https:\/\/doi.org\/10.1097\/01.ju.0000169424.79702.6d","journal-title":"J Urol"},{"issue":"4","key":"2438_CR22","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/S0022-5347(05)67137-6","volume":"164","author":"F Millian-Rodriguez","year":"2000","unstructured":"Millian-Rodriguez F, CheChile-Toniolo G, Salvador-Bayarri J, Huguet-Perez J, Vicente-Rodriguez J (2000) Upper urinary tract tumors after primary superficial bladder tumors: prognostic factors and risk groups. J Urol 164(4):1183\u20131187. https:\/\/doi.org\/10.1016\/S0022-5347(05)67137-6","journal-title":"J Urol"},{"issue":"3 Pt 1","key":"2438_CR23","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/S0022-5347(05)67280-1","volume":"164","author":"F Millan-Rodriguez","year":"2000","unstructured":"Millan-Rodriguez F, Chechile-Toniolo G, Salvador-Bayarri J, Palou J, Algaba F, Vicente-Rodriguez J (2000) Primary superficial bladder cancer risk groups according to progression, mortality and recurrence. J Urol 164(3 Pt 1):680\u2013684. https:\/\/doi.org\/10.1016\/S0022-5347(05)67280-1","journal-title":"J Urol"},{"issue":"4","key":"2438_CR24","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.eururo.2008.01.015","volume":"53","author":"RJ Sylvester","year":"2008","unstructured":"Sylvester RJ, Oosterlinck W, Witjes JA (2008) The schedule and duration of intravesical chemotherapy in patients with non-muscle-invasive bladder cancer: a systematic review of the published results of randomized clinical trials. Eur Urol 53(4):709\u2013719. https:\/\/doi.org\/10.1016\/j.eururo.2008.01.015","journal-title":"Eur Urol"},{"issue":"2","key":"2438_CR25","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.uro.2014.02.2573","volume":"192","author":"AM Kamat","year":"2014","unstructured":"Kamat AM, Witjes JA, Brausi M, Soloway M, Lamm D, Persad R, Buckley R, B\u00f6hle A, Colombel M, Palou J (2014) Defining and treating the spectrum of intermediate risk nonmuscle invasive bladder cancer. J Urol 192(2):305\u2013315. https:\/\/doi.org\/10.1016\/j.uro.2014.02.2573","journal-title":"J Urol"},{"issue":"2","key":"2438_CR26","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.urology.2009.08.082","volume":"75","author":"KT Adiyat","year":"2010","unstructured":"Adiyat KT, Katkoori D, Soloway CT, De los Santos R, Manoharan M, Soloway MS (2010) \u201cComplete transurethral resection of bladder tumor\u201d: are the guidelines being followed? Urology 75(2):365\u2013367. https:\/\/doi.org\/10.1016\/j.urology.2009.08.082","journal-title":"Urology"},{"issue":"3","key":"2438_CR27","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/cncr.29071","volume":"121","author":"K Chamie","year":"2015","unstructured":"Chamie K, Ballon-Landa E, Bassett JC, Daskivich TJ, Leventhal M, Deapen D, Litwin MS (2015) Quality of diagnostic staging in patients with bladder cancer: a process-outcomes link. Cancer 121(3):379\u2013385. https:\/\/doi.org\/10.1002\/cncr.29071","journal-title":"Cancer"},{"issue":"8","key":"2438_CR28","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.6004\/jnccn.2015.0123","volume":"13","author":"HW Herr","year":"2015","unstructured":"Herr HW (2015) Role of repeat resection in non-muscle-invasive bladder cancer. J Natl Compr Canc Netw 13(8):1041\u20131046. https:\/\/doi.org\/10.6004\/jnccn.2015.0123","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"2438_CR29","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.juro.2008.03.038","volume":"180","author":"T Cai","year":"2008","unstructured":"Cai T, Nesi G, Tinacci G, Zini E, Mondaini N, Boddi V, Mazzoli S, Bartoletti R (2008) Can early single dose instillation of epirubicin improve bacillus Calmette-Guerin efficacy in patients with nonmuscle invasive high risk bladder cancer? Results from a prospective, randomized, double-blind controlled study. J Urol 180(1):110\u2013115. https:\/\/doi.org\/10.1016\/j.juro.2008.03.038","journal-title":"J Urol"},{"issue":"5","key":"2438_CR30","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.juro.2016.12.090","volume":"197","author":"R Chou","year":"2017","unstructured":"Chou R, Selph S, Buckley DI, Fu R, Griffin JC, Grusing S, Gore JL (2017) Intravesical therapy for the treatment of nonmuscle invasive bladder cancer: a systematic review and meta-analysis. J Urol 197(5):1189\u20131199. https:\/\/doi.org\/10.1016\/j.juro.2016.12.090","journal-title":"J Urol"},{"issue":"4","key":"2438_CR31","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","volume":"163","author":"DL Lamm","year":"2000","unstructured":"Lamm DL, Blumenstein BA, Crissman JD, Montie JE, Gottesman JE, Lowe BA, Sarosdy MF, Bohl RD, Grossman HB, Beck TM, Leimert JT, Crawford ED (2000) Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest oncology group study. J Urol 163(4):1124\u20131129. https:\/\/doi.org\/10.1016\/S0022-5347(05)67707-5","journal-title":"J Urol"},{"issue":"7","key":"2438_CR32","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1046\/j.1464-410X.2002.02722.x","volume":"89","author":"JA Martinez-Pineiro","year":"2002","unstructured":"Martinez-Pineiro JA, Flores N, Isorna S, Solsona E, Sebastian JL, Pertusa C, Rioja LA, Martinez-Pineiro L, Vela R, Camacho JE, Nogueira JL, Pereira I, Resel L, Muntanola P, Galvis F, Chesa N, De Torres JA, Carballido J, Bernuy C, Arribas S, Madero R, For CUETO (Club Urologico Espanol de Tratamiento Oncologico) (2002) Long-term follow-up of a randomized prospective trial comparing a standard 81\u00a0mg dose of intravesical bacille Calmette-Guerin with a reduced dose of 27\u00a0mg in superficial bladder cancer. BJU int 89(7):671\u2013680. https:\/\/doi.org\/10.1046\/j.1464-410X.2002.02722.x","journal-title":"BJU int"},{"issue":"4","key":"2438_CR33","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.eururo.2011.07.010","volume":"60","author":"RJ Lammers","year":"2011","unstructured":"Lammers RJ, Witjes WP, Hendricksen K, Caris CT, Janzing-Pastors MH, Witjes JA (2011) Smoking status is a risk factor for recurrence after transurethral resection of non-muscle-invasive bladder cancer. Eur Urol 60(4):713\u2013720. https:\/\/doi.org\/10.1016\/j.eururo.2011.07.010","journal-title":"Eur Urol"},{"issue":"4","key":"2438_CR34","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.eururo.2012.08.025","volume":"63","author":"M Rink","year":"2013","unstructured":"Rink M, Furberg H, Zabor EC, Xylinas E, Babjuk M, Pycha A, Lotan Y, Karakiewicz PI, Novara G, Robinson BD, Montorsi F, Chun FK, Scherr DS, Shariat SF (2013) Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancer. Eur Urol 63(4):724\u2013732. https:\/\/doi.org\/10.1016\/j.eururo.2012.08.025","journal-title":"Eur Urol"},{"issue":"5","key":"2438_CR35","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1097\/01.ju.0000062605.92268.c6","volume":"169","author":"HW Herr","year":"2003","unstructured":"Herr HW, Dalbagni G (2003) Defining bacillus Calmette-Guerin refractory superficial bladder tumors. J Urol 169(5):1706\u20131708. https:\/\/doi.org\/10.1097\/01.ju.0000062605.92268.c6","journal-title":"J Urol"},{"issue":"6","key":"2438_CR36","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.juro.2016.01.087","volume":"195","author":"CR Haas","year":"2016","unstructured":"Haas CR, Barlow LJ, Badalato GM, DeCastro GJ, Benson MC, McKiernan JM (2016) The timing of radical cystectomy for bacillus Calmette-Guerin failure: comparison of outcomes and risk factors for prognosis. J Urol 195(6):1704\u20131709. https:\/\/doi.org\/10.1016\/j.juro.2016.01.087","journal-title":"J Urol"},{"issue":"2","key":"2438_CR37","doi-asserted-by":"publisher","first-page":"E15","DOI":"10.3390\/cancers9020015","volume":"9","author":"S Gupta","year":"2017","unstructured":"Gupta S, Gill D, Poole A, Agarwal N (2017) Systemic immunotherapy for urothelial cancer: current trends and future directions. Cancers 9(2):E15. https:\/\/doi.org\/10.3390\/cancers9020015","journal-title":"Cancers"},{"issue":"3","key":"2438_CR38","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S0022-5347(05)67799-3","volume":"163","author":"G Steinberg","year":"2000","unstructured":"Steinberg G, Bahnson R, Brosman S, Middleton R, Wajsman Z, Wehle M (2000) Efficacy and safety of valrubicin for the treatment of Bacillus Calmette-Guerin refractory carcinoma in situ of the bladder. The Valrubicin Study Group. J Urol 163(3):761\u2013767. https:\/\/doi.org\/10.1016\/S0022-5347(05)67799-3","journal-title":"J Urol"},{"issue":"3","key":"2438_CR39","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.juro.2012.10.068","volume":"189","author":"LJ Barlow","year":"2013","unstructured":"Barlow LJ, McKiernan JM, Benson MC (2013) Long-term survival outcomes with intravesical docetaxel for recurrent nonmuscle invasive bladder cancer after previous bacillus Calmette-Guerin therapy. J Urol 189(3):834\u2013839. https:\/\/doi.org\/10.1016\/j.juro.2012.10.068","journal-title":"J Urol"},{"issue":"2","key":"2438_CR40","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.urology.2007.09.050","volume":"71","author":"BL Gallagher","year":"2008","unstructured":"Gallagher BL, Joudi FN, Maymi JL, O\u2019Donnell MA (2008) Impact of previous bacille Calmette-Guerin failure pattern on subsequent response to bacille Calmette-Guerin plus interferon intravesical therapy. Urology 71(2):297\u2013301. https:\/\/doi.org\/10.1016\/j.urology.2007.09.050","journal-title":"Urology"},{"issue":"4","key":"2438_CR41","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/nrurol.2017.16","volume":"14","author":"AM Kamat","year":"2017","unstructured":"Kamat AM, Colombel M, Sundi D, Lamm D, Boehle A, Brausi M, Buckley R, Persad R, Palou J, Soloway M, Witjes JA (2017) BCG-unresponsive non-muscle-invasive bladder cancer: recommendations from the IBCG. Nat Rev Urol 14(4):244\u2013255. https:\/\/doi.org\/10.1038\/nrurol.2017.16","journal-title":"Nat Rev Urol"},{"issue":"1","key":"2438_CR42","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.eururo.2011.04.023","volume":"60","author":"RJ Lammers","year":"2011","unstructured":"Lammers RJ, Witjes JA, Inman BA, Leibovitch I, Laufer M, Nativ O, Colombo R (2011) The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of non-muscle-invasive bladder cancer: a systematic review. Eur Urol 60(1):81\u201393. https:\/\/doi.org\/10.1016\/j.eururo.2011.04.023","journal-title":"Eur Urol"},{"issue":"3","key":"2438_CR43","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1097\/01.ju.0000080568.91703.18","volume":"170","author":"SM Stasi Di","year":"2003","unstructured":"Di Stasi SM, Giannantoni A, Stephen RL, Capelli G, Navarra P, Massoud R, Vespasiani G (2003) Intravesical electromotive mitomycin C versus passive transport mitomycin C for high risk superficial bladder cancer: a prospective randomized study. J Urol 170(3):777\u2013782. https:\/\/doi.org\/10.1097\/01.ju.0000080568.91703.18","journal-title":"J Urol"},{"issue":"15","key":"2438_CR44","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1200\/JCO.2006.05.8149","volume":"24","author":"C Weiss","year":"2006","unstructured":"Weiss C, Wolze C, Engehausen DG, Ott OJ, Krause FS, Schrott KM, Dunst J, Sauer R, Rodel C (2006) Radiochemotherapy after transurethral resection for high-risk T1 bladder cancer: an alternative to intravesical therapy or early cystectomy? J Clin Oncol 24(15):2318\u20132324. https:\/\/doi.org\/10.1200\/JCO.2006.05.8149","journal-title":"J Clin Oncol"},{"issue":"4","key":"2438_CR45","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1464-410X.2008.08032.x","volume":"103","author":"A Karl","year":"2009","unstructured":"Karl A, Tritschler S, Stanislaus P, Gratzke C, Tilki D, Strittmatter F, Knuchel R, Stief CG, Zaak D (2009) Positive urine cytology but negative white-light cystoscopy: an indication for fluorescence cystoscopy? BJU Int 103(4):484\u2013487. https:\/\/doi.org\/10.1111\/j.1464-410X.2008.08032.x","journal-title":"BJU Int"},{"issue":"6","key":"2438_CR46","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1245\/s10434-016-5763-5","volume":"24","author":"A Gopalakrishna","year":"2017","unstructured":"Gopalakrishna A, Fantony JJ, Longo TA, Owusu R, Foo WC, Dash R, Denton BT, Inman BA (2017) Anticipatory positive urine tests for bladder cancer. Ann Surg Oncol 24(6):1747\u20131753. https:\/\/doi.org\/10.1245\/s10434-016-5763-5","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"2438_CR47","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1111\/j.1464-410X.2008.08238.x","volume":"103","author":"ER Ray","year":"2009","unstructured":"Ray ER, Chatterton K, Khan MS, Thomas K, Chandra A, O\u2019Brien TS (2009) Hexylaminolaevulinate \u2018blue light\u2019 fluorescence cystoscopy in the investigation of clinically unconfirmed positive urine cytology. BJU Int 103(10):1363\u20131367. https:\/\/doi.org\/10.1111\/j.1464-410X.2008.08238.x","journal-title":"BJU Int"},{"issue":"5","key":"2438_CR48","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.eururo.2005.12.019","volume":"49","author":"JP Redorta","year":"2006","unstructured":"Redorta JP, Schatteman P, Perez JH, Tomas JS, Bordes AR, Algaba F, Mavrich HV (2006) Intravesical instillations with bacillus Calmette-Guerin for the treatment of carcinoma in situ involving prostatic ducts. Eur Urol 49(5):834\u2013838. https:\/\/doi.org\/10.1016\/j.eururo.2005.12.019","journal-title":"Eur Urol"},{"issue":"6","key":"2438_CR49","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3816\/CGC.2007.n.021","volume":"5","author":"JH Taylor","year":"2007","unstructured":"Taylor JH, Davis J, Schellhammer P (2007) Long-term follow-up of intravesical bacillus Calmette-Guerin treatment for superficial transitional-cell carcinoma of the bladder involving the prostatic urethra. Clin Genitourin Cancer 5(6):386\u2013389. https:\/\/doi.org\/10.3816\/CGC.2007.n.021","journal-title":"Clin Genitourin Cancer"},{"issue":"6","key":"2438_CR50","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1111\/bju.12486","volume":"114","author":"JJ Knoedler","year":"2014","unstructured":"Knoedler JJ, Boorjian SA, Tollefson MK, Cheville JC, Thapa P, Tarrell RF, Frank I (2014) Urothelial carcinoma involving the prostate: the association of revised tumour stage and coexistent bladder cancer with survival after radical cystectomy. BJU int 114(6):832\u2013836. https:\/\/doi.org\/10.1111\/bju.12486","journal-title":"BJU int"},{"issue":"6","key":"2438_CR51","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1200\/JCO.2014.57.6967","volume":"33","author":"W Martin-Doyle","year":"2015","unstructured":"Martin-Doyle W, Leow JJ, Orsola A, Chang SL, Bellmunt J (2015) Improving selection criteria for early cystectomy in high-grade t1 bladder cancer: a meta-analysis of 15,215 patients. J Clin Oncol 33(6):643\u2013650. https:\/\/doi.org\/10.1200\/JCO.2014.57.6967","journal-title":"J Clin Oncol"},{"issue":"4","key":"2438_CR52","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/S0022-5347(05)65756-4","volume":"166","author":"HW Herr","year":"2001","unstructured":"Herr HW, Sogani PC (2001) Does early cystectomy improve the survival of patients with high risk superficial bladder tumors? J Urol 166(4):1296\u20131299. https:\/\/doi.org\/10.1016\/S0022-5347(05)65756-4","journal-title":"J Urol"},{"issue":"2","key":"2438_CR53","doi-asserted-by":"publisher","first-page":"66.e25","DOI":"10.1016\/j.urolonc.2014.06.008","volume":"33","author":"FA Yafi","year":"2015","unstructured":"Yafi FA, Brimo F, Steinberg J, Aprikian AG, Tanguay S, Kassouf W (2015) Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer. Urol Oncol 33(2):66.e25\u201366.e31. https:\/\/doi.org\/10.1016\/j.urolonc.2014.06.008","journal-title":"Urol Oncol"},{"issue":"6 Suppl 1","key":"2438_CR54","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.urology.2005.08.064","volume":"66","author":"VB Lokeshwar","year":"2005","unstructured":"Lokeshwar VB, Habuchi T, Grossman HB, Murphy WM, Hautmann SH, Hemstreet GP 3rd, Bono AV, Getzenberg RH, Goebell P, Schmitz-Drager BJ, Schalken JA, Frade Y, Marberger M, Messing E, Droller MJ (2005) Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers. Urology 66(6 Suppl 1):35\u201363. https:\/\/doi.org\/10.1016\/j.urology.2005.08.064","journal-title":"Urology"},{"key":"2438_CR55","unstructured":"Kassouf W, Witjes JA et al. (2018) ICUD-SIU International Consultation on Bladder Cancer 2017: management of non-muscle invasive bladder cancer. ICUD-SIU bladder guideline book (NMIBC section). In: Black, P and Gontero, P (eds). https:\/\/www.siu-urology.org\/society\/siu-icud . Accessed 10 May 2018"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-018-2438-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-018-2438-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-018-2438-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T05:58:06Z","timestamp":1661752686000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-018-2438-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,14]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["2438"],"URL":"https:\/\/doi.org\/10.1007\/s00345-018-2438-9","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,14]]},"assertion":[{"value":"5 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Author JA Witjes has relationship with Sanofi Pasteur, MEL Amsterdam (Synergo), Cepheid, Nucleix, BMS, Taris, BioCancel and Spectrum. Author SS Chang has relationship with Mdx Health, BioCancel, Bristol Myers Squibb, and Altor. Author GS Kulkarni has received research funds from Biosyent Canada. Author MA O\u2019Donnell has relationship with Abbot Molecular, Roche, Photocure, Urogen, Medical Enterprises, Viventia, Spectrum, Fidia Pharmaceuticals, Vaxiion Pharmaceuticals, and Therlasae. The other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this type of study formal consent is not required. This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"For this type of study formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}